Biologic Therapies | Salem, VA
Platelet Rich Plasma (PRP) Therapy, Stem Cell Therapy and Bioinductive Implants are targeted biologic therapies, which means they are designed to help a patient’s body heal itself. These therapies offer an excellent option for treating ailments that have not improved following conservative, non-surgical treatments, including rest, medications and physical therapy.
PRP Therapy is used at Virginia Orthopaedic to treat a variety of orthopaedic-related injuries. Platelets are tiny cells containing thousands of growth factors that control and regulate the natural healing process by recruiting stem cells to the injured site. These platelets are obtained by a simple blood draw from the patient. Once the blood is extracted, it is spun in a centrifuge to obtain the highest possible concentration of nutrients. These platelets are then injected at the site of injury or pain. Over the next two to three months, the platelets begin a natural healing process of the injured site.
Stem Cell Therapy
Stem Cell Therapy is used at Virginia Orthopaedic to treat patients who are suffering from various injuries and degenerative conditions that limit mobility, are difficult to heal and may lead to surgery if left untreated.
Stem cells contain collagens, growth factors and bioactive molecules, which are essential to support the body’s repair process. This therapy, performed in a matter of minutes, is applied by a simple injection directly into the injured area, which is located by using advanced imaging and manual touch. Most patients only require a single treatment and may experience relief as soon as 3-10 days after treatment, continuing to improve over the following weeks and months.
Derived from bovine Achilles tendon, bioinductive implants are designed to address both the biomechanics and biology required to heal a rotator cuff tendon tear by inducing new tissue growth at the site of implantation. About the size of a postage stamp, this collagen-based implant results in increased tendon thickness and healing of tendon defects with new tissue growth.
According to Rotation Medical, rotator cuff damage is the most common source of shoulder pain, affecting more than 4 million people annually in the U.S. Traditional approaches to treating degenerative or torn rotator cuffs often do not address the poor quality of the underlying tendon tissue, and a significant number of these tendons, after standard treatment, degenerate further and/or re-tear.